GFAP and Alzheimer disease: Meanwhile, OT administration also significantly inhibited the upregulation of total AQP4 expression in AD mice (Figure S5), indicating the attenuation of astrogliosis, further supported by similar level changes in glial fibrillary acidic protein (GFAP), a typical marker of astrocytes (Figure 2L).